# Amgen Inc: Form 8-K, filed Jun 3, 2024

- Company: [Amgen Inc](/companies/amgn.md) (CIK 318154)
- Form: 8-K
- Filed: 2024-06-03
- Accepted by EDGAR: Jun 3, 2024, 17:17 ET
- Period: 2024-05-31
- Accession: 0001193125-24-153221
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/318154/000119312524153221/d827769d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/318154/000119312524153221/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/318154/000119312524153221/d827769d8k.htm

Filed Jun 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-153221. Last ingested by Listed: Nov 10, 2026, 06:19 ET. No prices; not investment advice.